PARADISI, FRANCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 6.557
NA - Nord America 5.957
AS - Asia 599
AF - Africa 42
SA - Sud America 24
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 13.184
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.930
PL - Polonia 3.287
UA - Ucraina 743
IE - Irlanda 596
SE - Svezia 542
DE - Germania 473
IT - Italia 472
HK - Hong Kong 315
FI - Finlandia 220
GB - Regno Unito 115
CN - Cina 88
FR - Francia 54
VN - Vietnam 54
TR - Turchia 48
SC - Seychelles 39
KR - Corea 27
CA - Canada 25
JO - Giordania 24
BG - Bulgaria 16
TH - Thailandia 15
SG - Singapore 10
AR - Argentina 9
BO - Bolivia 7
NL - Olanda 7
IR - Iran 6
PT - Portogallo 6
BR - Brasile 5
AL - Albania 4
CZ - Repubblica Ceca 4
IN - India 4
RU - Federazione Russa 4
AT - Austria 3
CH - Svizzera 3
CO - Colombia 3
AU - Australia 2
BE - Belgio 2
IL - Israele 2
IQ - Iraq 2
JP - Giappone 2
NZ - Nuova Zelanda 2
TT - Trinidad e Tobago 2
DK - Danimarca 1
EE - Estonia 1
ES - Italia 1
EU - Europa 1
GH - Ghana 1
GR - Grecia 1
KH - Cambogia 1
LU - Lussemburgo 1
MU - Mauritius 1
MZ - Mozambico 1
PK - Pakistan 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 13.184
Salva come PNG Salva come JPEG
Città #
Warsaw 3.286
Jacksonville 1.137
Chandler 701
Dublin 596
Fairfield 539
Wilmington 299
Cambridge 275
Woodbridge 242
Boardman 215
Princeton 212
Ashburn 206
Houston 183
Boston 171
Seattle 161
Hong Kong 138
Ann Arbor 89
Medford 86
Buffalo 80
Lawrence 77
Altamura 76
Beijing 65
Los Angeles 57
New York 53
San Diego 50
Dong Ket 49
Auburn Hills 46
Frankfurt Am Main 44
Izmir 41
Norwalk 41
Milan 39
Verona 33
Hillsboro 32
Andover 26
Florence 25
Toronto 21
Dearborn 16
Kent 15
Sofia 15
Bremen 14
Bangkok 13
Phoenix 12
Seongnam 12
Redwood City 11
San Mateo 11
Shanghai 11
London 10
Rome 10
Seoul 10
Helsinki 8
Laurel 8
Catania 7
Buenos Aires 5
Santa Cruz 5
Delray Beach 4
Falls Church 4
Padova 4
Portland 4
Singapore 4
Augusta 3
Decatur 3
Hanover 3
Kilburn 3
Leawood 3
Montréal 3
Prato 3
Westerville 3
Aci Catena 2
Acton 2
Arnsberg 2
Arten 2
Auckland 2
Brescia 2
Brussels 2
Cantagallo 2
Chon Buri 2
Foresto 2
Forlì 2
Frattamaggiore 2
Lisbon 2
Milazzo 2
Modena 2
Mountain View 2
Munro 2
Naples 2
Perugia 2
Piansano 2
Port of Spain 2
Prescot 2
Rizziconi 2
Rotterdam 2
Spinetoli 2
Tappahannock 2
Valle 2
Accra 1
Acquasparta 1
Aigaleo 1
Alba 1
Anaheim 1
Ardabil 1
Arezzo 1
Totale 9.689
Salva come PNG Salva come JPEG
Nome #
Antistaphylococcal (MSSA, MRSA, MSSE, MRSE) antibiotics 261
Urinary tract infections in the city of Florence: epidemiological considerations over a twenty-year period 221
Is Streptococcus pneumoniae a nosocomially acquired pathogen? 218
Skeletal tuberculosis and other granulomatous infections 218
Invasive Streptococcus pyogenes infection in a surgeon after an occupational exposure 208
Antibiotic resistance in community-acquired pulmonary pathogens 208
Streptococcus pneumoniae as an agent of nosocomial infection: treatment in the era of penicillin-resistant strains 208
Which prophylactic regimen for which surgical procedure? 207
Effect of antibiotic pretreatment on resistance 206
Once-daily dosing regimen for aminoglycoside plus betalactam combination therapy of serious lower respiratory tract infections 204
Infections in multiple myeloma 202
Ciprofloxacin resistance in clinical isolates of Pseudomonas aeruginosa from Italian patients 197
Clinical and microbiologic efficacy and safety profile of linezolid, a new oxazolidinone antibiotic 194
Antimicrobial resistance in an intensive care unit before adopting an antibiotic rotation programme for empiric therapy of ventilator-associated pneumonia 185
Multicenter randomized trial comparing meropenem (1.5 g daily) and imipenem/cilastatin (2 g daily) in the hospital treatment of community-acquired pneumonia 184
La terapia delle infezioni fungine invasive: dubbi e certezze 180
Toscana virus, a “Mediterranean” agent of aseptic meningitis: analysis of 42 consecutive cases 177
Ruolo del linezolid nella terapia delle infezioni causate da cocchi gram-positivi multiresistenti 177
Nuove prospettive terapeutiche nel trattamento delle infezioni in comunità 177
Penetrazione degli antibiotici in distretti speciali 171
Treatment of otitis media 171
Terapia delle infezioni intra-addominali complicate: qualcosa è cambiato nel nostro orizzonte terapeutico? 167
Pathogenetic mechanisms responsible for the production of secondary immunodeficiency 167
Nuove prospettive terapeutiche: fra presente e futuro 164
Terapia antibiotica delle polmoniti nosocomiali 162
Atassia cerebellare acuta in corso di mononucleosi infettiva 135
Antibiotic resistance in the absence of antimicrobial use: mechanisms and implications. 119
Epidemiology of pneumococcal resistance in Florence: much more erythromycin-nonsusceptible (ENSP) than penicillin-nonsusceptible (PNSP) strains 102
Antibiotic usage and risk of colonization and infection with antibiotic-resistant bacteria: a hospital population-based study 89
Resistenza a ciprofloxacin di stafilococchi coagulasi-negativi meticillino-resistenti isolati nell'area fiorentina 83
Is Streptococcus pneumoniae a nosocomially-acquired pathogen? 82
Severe head and neck infections in the critical care unit 80
Incidence of penicillin- (PNSP) and erythromycin- (ENSP) nonsusceptible pneumococci in Florence, Italy, 1992-1999 80
The influence of ofloxacin versus trimethoprim-sulfamethoxazole on the aerobic flora in granulocytopenic subjects. 80
Post-traumatic infection of the lower limb caused by rare Enterobacteriaceae and Mucorales in a young healthy male 80
High prevalence of acquired antimicrobial resistance unrelated to heavy antimicrobial consumption 80
Molecular alterations of VanA element in vancomycin-resistant enterococci isolated during a survey of colonized patients in an Italian intensive care unit. 79
In vitro activity of MDL 62,879 against Gram-positive bacteria and bacteroides species 77
Effect of a new fluorinated quinolone (ofloxacin) on the chemiluminescence of phagocytosing human neutrophils. 73
Secondary immunodeficiency 72
Serological survey of toxoplasmosis in the Santa Cruz region of Bolivia. 71
Distribution and antibiotic resistance of isolates from lower respiratory tract and blood cultures from patients in three Italian intensive care units: a 2-year comparison. 71
Evaluation of a rapid immunochromatographic test for serologic diagnosis of tuberculosis in Italy 70
Epilepsy, cysticercosis, and toxocariasis: a population-based case-control study in rural Bolivia. 70
High prevalence of acquired antimicrobial resistance unrelated to heavy antimicrobial consumption 69
A neuroepidemiological survey in rural Bolivia: background and methods. 69
Seroprevalence of varicella zoster and rubella antibodies among rural populations of the Chaco region, south-eastern Bolivia. 69
Population movements and cholera spread in Cordillera Province, Santa Cruz Department, Bolivia. 69
Parasitological observations on three Bolivian localities including rural communities, cities and institutions. 68
Prevalence of epilepsy in rural Bolivia: a door-to-door survey. 67
Urosepsis in the critical care unit. 67
Prevalence of leptospiral infections in humans in Cordillera Province, Bolivia. 66
Lumbar pain in a married couple who likes cheese: brucella strikes again! 65
Prevalence of antibodies against hepatitis A and E viruses among rural populations of the Chaco region, south-eastern Bolivia. 65
Different broth dilution procedures generate different apparent MICs for ramoplanin 65
Treatment of multidrug-resistant tuberculosis 64
Patterns of antimicrobial use and antimicrobial resistance among healthy children in Bolivia. 63
High-level aminoglycoside resistance among enterococci isolated from blood cultures. 62
Intestinal parasites in the Camiri, Gutierrez and Boyuibe areas, Santa Cruz Department, Bolivia. 62
Considerazioni farmacoeconomiche sulla terapia antibiotica delle infezioni osteo-articolari 61
Absence of HIV infection in low- and high-risk groups in the Santa Cruz region, Bolivia. 58
Le resistenze batteriche mediate da beta-lattamasi a spettro esteso: conseguenze terapeutiche 58
Meropenem versus imipenem/cilastatin in the hospital treatment of community-acquired pneumonia 56
Antimicrobial agent susceptibility patterns of staphylococci isolated in urban and rural areas of Bolivia 55
Attività comparativa in vitro di meropenem, nuova molecola carbapenemica, nei confronti di batteri gram-positivi e gram-negativi 55
Proposal of an improved score method for the diagnosis of pulmonary tuberculosis in childhood in developing countries. 54
Cefepime 53
Alternative antibiotics for methicillin-resistant (MR) staphylococcal skin lesions in at-risk patients: preliminary results of a surveillance programme in Florence, Italy 52
The link between use of antibiotics and acquisition of methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci (VRE), and ciprofloxacin-resistant Pseudomonas aeruginosa (CR-PA) in a cohort of 864 patients 52
Terapia delle infezioni batteriche delle vie respiratorie inferiori nell'anziano 51
Attività comparativa in vitro di MDL 62873 nei confronti di microrganismi gram-positivi 50
Interactions between antibiotics and immune system 49
Attività in vitro di MDL 62,879 nei confronti di isolati clinici di E.faecalis con e senza resistenza ad altri livelli di aminoglucosidi 49
Approccio terapeutico alle infezioni nosocomiali 48
La terapia delle faringo-tonsilliti oggi: quali scelte terapeutiche? 47
Antimicrobial resistance (AR) among respiratory pathogens (RP): a unique epidemiology in Italy 47
Lo stafilococco meticillino-resistente: una realtà importante nell’attuale panorama della patologia infettiva 46
Bacterial infections of the gastrointestinal tract in HIV-infected patients 46
La mononucleosi infezione degli anni verdi 46
Mixed infection of the lower limb caused by rare bacterial and fungal pathogens in a patient with multiple traumatic injuries 46
Frequenza d'isolamento e sensibilità agli antibiotici di microrganismi isolati da urinocolture nel secondo semestre 1990 45
Antibiotic resistance of Enterobacteriaceae isolated from the urinary tract 45
Ruolo delle streptogramine nelle infezioni da microrganismi gram-positivi 45
Acquired immunodeficiency 44
Terapia delle infezioni delle vie respiratorie inferiori 44
Antibiotic susceptibility of urinary pathogens isolated from hospital practice specimens in the Florence area 44
Multicenter randomised trial comparing meropenem and imipenem cilastatin in the hospital treatment of community acquired pneumonia 44
Enterococchi e resistenza ad alti livelli di aminoglucosidi: indagine su isolati da emocolture nell'area fiorentina nel periodo 1990-94 44
Incidence of glycopeptide-resistant enterococci and use of glycopeptides in a Florence hospital 43
Utilizzo dei carbapenemici nella terapia delle infezioni intraddominali 43
Eradication of beta-haemolytic streptococci from the pharynx of healthy carriers with a single dose of ceftriaxone. 43
Seroepidemiological study of HIV antibody prevalence in the Santa Cruz region, Bolivia. 43
In vitro antibacterial activity of imipenem and other agents against Gram-negative and Gram-positive strains isolated from clinical specimens 43
Seroepidemiological study of HIV antibody prevalence in the Santa Cruz region (Bolivia) 43
Meropenem, a new carbapenem: in vitro activity against gram-positive and gram-negative bacteria 43
The role of atypical pathogens in the etiology of community-acquired pneumonia (CAP) in the Florence area 43
Pneumococco penicillino- ed eritromicino-insensibile nell’area fiorentina: una realtà epidemiologica in mutamento? 43
Le resistenze batteriche nelle ICU: conseguenze terapeutiche 42
Antibiotic therapy of bacterial meningitis 42
Resistenze batteriche tra gli agenti responsabili di infezioni delle vie aeree superiori 42
Totale 9.364
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.508
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.508
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019214 0 0 0 0 0 0 0 0 0 0 0 214
2019/20202.543 135 346 80 288 205 329 176 369 154 118 323 20
2020/20212.422 184 140 259 278 66 366 83 244 132 338 48 284
2021/20221.055 41 168 9 89 21 24 28 73 24 25 269 284
2022/20232.708 318 227 67 250 306 643 255 154 311 38 109 30
2023/2024877 69 139 224 102 52 79 17 153 2 12 28 0
Totale 13.212